Pharmacists to take over Treatment of Long-Term Illnesses
Treatment of patients with long term illnesses like Parkinson's and he...Proposals have been made to train some ''expert chemists in order t...Besides this some will also hold their own specialist clinics for pa...These reforms are a part of key NHS plans which will move more patie...However doctors and patient groups warned that the move could switch...
Treatment of patients with long term illnesses like Parkinson's and heart disease will soon be handled by pharmacists according to yesterday’s announcement.//
Proposals have been made to train some ''expert chemists" in order to take over the assessment of patients' medical conditions and management of their drugs, from GPs.
Besides this some will also hold their own specialist clinics for patients with life-threatening conditions like diabetes and asthma.
These reforms are a part of key NHS plans which will move more patient care into the community and so that the burden on overcrowded GP surgeries and hospitals is eased.
However doctors and patient groups warned that the move could switch care away from expert care and could spell worse healthcare for patients.
In addition they warned that confusion among patients as to whether they should visit their GP or pharmacist was also bound to come forth.
As per the new reforms, patients would still go to their GP for diagnosis but could then be referred to a high-street chemist for regular follow-up treatment and advice.
In addition some pharmacists will also be offered further training to in conditions like skin disorders and sexually-transmitted infections, as well as the management of drugs that prevent strokes and heart disease.
They would have separate rooms to carry out simple examinations and blood tests needed to make prescriptions.
Patient groups fear that although expert doctors would still be making the major decisions and diagnoses, pharmacists might step into this territory as well.
Joyce Robins, co-director of the campaign group Patient Concern said: "There are dangers in going down this kind of way. It is trying to do things on the cheap, like a lot of things on the health service."
"We are very, very cautious about this and can't really see how this is going to work.
(Date:12/2/2008)... CHICAGO, Dec. 2 Breast-Specific ...ly sensitive imaging technique for the diagnosis o...o diagnose breast cancer. BSGI,is a molecular bre...dent of,tissue density and discover very early st...ound and magnetic resonance imaging (MRI), BSGI ha...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 U...lvania children the opportunity to become "health,... designing programs to,address it and implementin...edHealth HEROES is a service-learning, health lite...e, working through educators and youth,leaders, t...
(Date:12/2/2008)... Money may be better spent in other areas, expert...s) -- Hospital rapid response teams, created to pr...patients, do not seem to work, a new study finds. ...over the past decade," said lead researcher Dr. Pa...t Institute in Kansas City, Mo. "Earlier studies h...
(Date:12/2/2008)... , The Health Story Proje...he project formerly known as “Clinical Docum...(CDA4CDT). CDA4CDT will continue as the label for ...nd submitted to Health Level Seven (HL7) for ballo... (Business Wire EON) December 2, 2008 -- "Ou...
...led that there has been an increase in heart failu...s are higher among women, // with men surviving f...n the incidence of heart failures during the 1990 ...eriod, in the case of people aged over 65 years, a...
...ent has approved the drug TEMODAL in combination w...astoma multiforme brain cancer. // The drug TEMODA...ng-Plough Corporation and is used in treating two ...forme and anaplastic astrocytoma. Clinical study ...
...to India’s National Institute of Immunology are re...ch helps us to understand how the tuberculosis (TB...ll help in developing newer and more effective med...y as 2 million lives across the world annually. Th...
... the worst possible results does not serve any pur...he disappointment in the end is the same for both ...ttle Pacific University and Jonathon Brown of the ...hnique of ‘defensive pessimism’ and reported their...
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)... CHICAGO, Dec. 2 A stu...EM), a new technique for imaging the breast, is no...ormonal status, two factors that limit the effecti...g cancer. Results will be presented today at the a... America (RSNA). , , "The ability of PEM t...
(Date:12/1/2008)...1 S*BIO Pte Ltd today announced th...18, a potent and orally-active JAK2 inhibitor, in ...with chronic idiopathic myelofibrosis (CIMF). , ...ty and tolerability of SB1518 in patients with CIM... Phase 1 part of the study will assess the safety ...
(Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
...ion during the,early post-operative period compare...ion in nausea in the female,patient population com... CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambrid...tional data from post-hoc analysis of the recent P...nide) in over 500 patients,with post-operative pai...
...0%; mso-hyphenate: none">,BUDAPEST, Hungary, June,...sands of patients with cancer from suffering,unnec...ngress of,the European Association for Palliative ...ated whether this first in class novel,formulation...,duration of effect, mirroring the breakthrough pa...
...nce, the SZX7 is designed for ease of use and work...ns to advanced research. The SZX7 offers one of th...ding image clarity, true color and accurate reprod...ined detail. System modularity and abundant access...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility.